<scp>MYC</scp> protein expression is associated with poor prognosis in primary diffuse large B‐cell lymphoma of the central nervous system
Gustavo Tapia(Hospital Universitari Germans Trias i Pujol), José Luís Mate(Universitat Autònoma de Barcelona), Carolina Sanz(Hôpital Larrey), Ruth Marginet‐Flinch(Universitat Autònoma de Barcelona), Ayman Gaafar(University of the Basque Country), Juan‐Manuel Sancho(Hospital Universitari Germans Trias i Pujol), Josep‐María Ribera(Universitat Autònoma de Barcelona), Ana M Muñoz‐Mármol(Universitat Autònoma de Barcelona), Maria João Baptista(Josep Carreras Leukaemia Research Institute), Aurelio Ariza(Universitat Autònoma de Barcelona), Maria Puente‐Pomposo(Hospital de Cruces), Olga García(Universitat Autònoma de Barcelona), José‐Tomás Navarro(Universitat Autònoma de Barcelona)
Cited by 28
Related Papers
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2016|457
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL
|Blood|2016|329